185 related articles for article (PubMed ID: 34456863)
1. The Associations of Serum Osteocalcin and Cortisol Levels With the Psychological Performance in Primary Hyperparathyroidism Patients.
Wang SM; He Y; Zhu MT; Tao B; Zhao HY; Sun LH; Liu JM
Front Endocrinol (Lausanne); 2021; 12():692722. PubMed ID: 34456863
[TBL] [Abstract][Full Text] [Related]
2. Depressive and anxiety disorders in patients with primary hyperparathyroidism.
Kunert Ł; Gawrychowski J; Sobiś J; Buła G; Pudlo R
Psychiatr Pol; 2020 Dec; 54(6):1091-1107. PubMed ID: 33740798
[TBL] [Abstract][Full Text] [Related]
3. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism.
Roman SA; Sosa JA; Pietrzak RH; Snyder PJ; Thomas DC; Udelsman R; Mayes L
Ann Surg; 2011 Jan; 253(1):131-7. PubMed ID: 21233611
[TBL] [Abstract][Full Text] [Related]
4. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.
Weber T; Keller M; Hense I; Pietsch A; Hinz U; Schilling T; Nawroth P; Klar E; Büchler MW
World J Surg; 2007 Jun; 31(6):1202-9. PubMed ID: 17460812
[TBL] [Abstract][Full Text] [Related]
5. May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?
Gianotti L; Tassone F; Pia A; Bovio S; Reimondo G; Visconti G; Terzolo M; Borretta G
Calcif Tissue Int; 2009 Jun; 84(6):425-9. PubMed ID: 19381429
[TBL] [Abstract][Full Text] [Related]
6. Interrelationship between bone turnover markers, calciotropic hormones and leptin in obese Saudi children.
Saber LM; Mahran HN; Baghdadi HH; Al Hawsawi ZM
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4332-43. PubMed ID: 26636521
[TBL] [Abstract][Full Text] [Related]
7. Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism.
Nevo-Shor A; Kogan S; Joshua BZ; Bahat-Dinur A; Novack V; Fraenkel M
Bone; 2016 Aug; 89():59-63. PubMed ID: 27260647
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.
Wang X; Shapses SA; Wei S; Sukumar D; Ghosh J
Endocr Pract; 2013; 19(4):609-13. PubMed ID: 23425651
[TBL] [Abstract][Full Text] [Related]
9. Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions.
Fillée C; Keller T; Mourad M; Brinkmann T; Ketelslegers JM
Clin Endocrinol (Oxf); 2012 Jun; 76(6):785-9. PubMed ID: 22066864
[TBL] [Abstract][Full Text] [Related]
10. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals.
Nielsen HK; Laurberg P; Brixen K; Mosekilde L
Acta Endocrinol (Copenh); 1991 Apr; 124(4):391-8. PubMed ID: 2031437
[TBL] [Abstract][Full Text] [Related]
11. Correlation of perioperative biochemical variables with single adenoma weight in patients with primary hyperparathyroidism.
Papadakis M; Weyerbrock N; Zirngibl H; Dotzenrath C
BMC Surg; 2020 Nov; 20(1):303. PubMed ID: 33256695
[TBL] [Abstract][Full Text] [Related]
12. Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.
Bergenfelz A; Valdermarsson S; Ahrén B
Horm Res; 1993; 39(3-4):146-51. PubMed ID: 8262476
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological features in primary hyperparathyroidism: a prospective study.
Walker MD; McMahon DJ; Inabnet WB; Lazar RM; Brown I; Vardy S; Cosman F; Silverberg SJ
J Clin Endocrinol Metab; 2009 Jun; 94(6):1951-8. PubMed ID: 19336505
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.
Inoue Y; Kaji H; Hisa I; Tobimatsu T; Naito J; Iu MF; Sugimoto T; Chihara K
Endocr J; 2008 Mar; 55(1):57-65. PubMed ID: 18187872
[TBL] [Abstract][Full Text] [Related]
18. Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism.
Meng L; Su C; Shapses SA; Al-Dayyeni A; He Y; Wang X
J Steroid Biochem Mol Biol; 2020 May; 199():105616. PubMed ID: 32027935
[TBL] [Abstract][Full Text] [Related]
19. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
[TBL] [Abstract][Full Text] [Related]
20. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
